ACTA2 | Actin, alpha 2, smooth muscle, aorta | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACTB | Actin, beta | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACTBL2 | Actin, beta-like 2 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Not detected |
ACTC1 | Actin, alpha, cardiac muscle 1 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ACTG1 | Actin, gamma 1 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACTL6A | Actin-like 6A | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACTN1 | Actinin, alpha 1 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACTN2 | Actinin, alpha 2 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ACTN3 | Actinin, alpha 3 (gene/pseudogene) | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ACTN4 | Actinin, alpha 4 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACTR1A | ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACTR1B | ARP1 actin-related protein 1 homolog B, centractin beta (yeast) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACTR2 | ARP2 actin-related protein 2 homolog (yeast) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACTR3 | ARP3 actin-related protein 3 homolog (yeast) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM19 | ADAM metallopeptidase domain 19 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Mixed |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM30 | ADAM metallopeptidase domain 30 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADAM7 | ADAM metallopeptidase domain 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM9 | ADAM metallopeptidase domain 9 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Mixed |
ADAMTS7 | ADAM metallopeptidase with thrombospondin type 1 motif, 7 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL2 | ADAMTS-like 2 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAR | Adenosine deaminase, RNA-specific | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ADARB1 | Adenosine deaminase, RNA-specific, B1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY4 | Adenylate cyclase 4 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ADD1 | Adducin 1 (alpha) | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADH1C | Alcohol dehydrogenase 1C (class I), gamma polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADH5 | Alcohol dehydrogenase 5 (class III), chi polypeptide | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADIRF | Adipogenesis regulatory factor | Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
ADM | Adrenomedullin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADRA1B | Adrenoceptor alpha 1B | Cancer-related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1D | Adrenoceptor alpha 1D | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRBK1 | Adrenergic, beta, receptor kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADSS | Adenylosuccinate synthase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |